Efavirenz
Efavirenz is a pharmaceutical drug with 169 clinical trials. Currently 2 active trials ongoing. Historical success rate of 94.7%.
Success Metrics
Based on 143 completed trials
Phase Distribution
Phase Distribution
35
Early Stage
36
Mid Stage
65
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.5%
143 of 153 finished
6.5%
10 ended early
2
trials recruiting
169
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants
A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
Efavirenz for the Treatment of Creutzfeldt-Jakob Disease
Reverse Triple Negative Immune Resistant Breast Cancer
Clinical Trials (169)
Effects of Efavirenz on the Pharmacokinetics of Suzetrigine in Healthy Participants
A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
Efavirenz for the Treatment of Creutzfeldt-Jakob Disease
Reverse Triple Negative Immune Resistant Breast Cancer
Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)
Drug-Drug Interaction Potential of Mavorixafor
An Open-label DDI Study of Omaveloxolone in Healthy Subjects
A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)
REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
Pharmacologic Strategies to Use the Levonorgestrel Implant in HIV-infected Women
A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants
A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults
EFV Pharmacokinetics & Pharmacogenomics in Older HIV-infected Patients
A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy
Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants
Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 169